ATP13A2 Antikörper (AA 200-300)
(1 reference)-
- Target Alle ATP13A2 Antikörper anzeigen
- ATP13A2 (ATPase Type 13A2 (ATP13A2))
-
Bindungsspezifität
- AA 200-300
-
Reaktivität
- Human, Maus
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser ATP13A2 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC)
- Verwendungszweck
- Rabbit polyclonal antibody raised against synthetic peptide of ATP13A2.
- Kreuzreaktivität
- Human, Maus
- Produktmerkmale
- Antibody Reactive Against Synthetic Peptide.
- Immunogen
- A synthetic peptide corresponding to amino acids 200-300 of human ATP13A2.
-
anti-ATPase Type 13A2 (ATP13A2) (AA 68-154) antibody
ATP13A2 Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 4B7 unconjugated
anti-ATPase Type 13A2 (ATP13A2) (AA 582-736) antibodyATP13A2 Reaktivität: Human ELISA, IF Wirt: Kaninchen Polyclonal unconjugated
anti-ATPase Type 13A2 (ATP13A2) (AA 1001-1080) antibodyATP13A2 Reaktivität: Ratte ELISA, IF (cc), IF (p), IHC (fro), IHC (p), ICC Wirt: Kaninchen Polyclonal unconjugated
anti-ATPase Type 13A2 (ATP13A2) (AA 68-154) antibodyATP13A2 Reaktivität: Human WB, ELISA Wirt: Maus Polyclonal unconjugated
anti-ATPase Type 13A2 (ATP13A2) (AA 195-209) antibodyATP13A2 Reaktivität: Human, Ratte IHC Wirt: Kaninchen Polyclonal unconjugated
anti-ATPase Type 13A2 (ATP13A2) (AA 147-161) antibodyATP13A2 Reaktivität: Maus IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-ATPase Type 13A2 (ATP13A2) (AA 67-210) antibodyATP13A2 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
-
Western Blot (2 μg/mL)
Immunohistochemistry (10-20 μg/mL)
The optimal working dilution should be determined by the end user. - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- In Tris-glycine, 150 mM NaCl (0.05 % sodium azide)
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
-
Store at -20°C or -80°C.
Aliquot to avoid repeated freezing and thawing.
-
-
: "Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase." in: Nature genetics, Vol. 38, Issue 10, pp. 1184-91, (2006) (PubMed).
-
: "Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase." in: Nature genetics, Vol. 38, Issue 10, pp. 1184-91, (2006) (PubMed).
-
- Target
- ATP13A2 (ATPase Type 13A2 (ATP13A2))
- Andere Bezeichnung
- ATP13A2 / PARK9 (ATP13A2 Produkte)
- Synonyme
- ATP13A2 antikoerper, 1110012E06Rik antikoerper, AA589443 antikoerper, RGD1307977 antikoerper, im:7147302 antikoerper, zgc:136762 antikoerper, CLN12 antikoerper, HSA9947 antikoerper, KRPPD antikoerper, PARK9 antikoerper, ATPase 13A2 antikoerper, ATPase type 13A2 antikoerper, probable cation-transporting ATPase 13A2 antikoerper, ATP13A2 antikoerper, Atp13a2 antikoerper, atp13a2 antikoerper, PTRG_01071 antikoerper, MCYG_01937 antikoerper, LOC100439053 antikoerper
- Gen-ID
- 23400
- Pathways
- Ribonucleoside Biosynthetic Process
-
